× Industry Reports Services Press Release Contact us About us

Europe Aquaculture Vaccines Market Size By Route of Administration (Immersion Vaccines, Injection Vaccines, Oral Vaccines), By Type (Inactivated Vaccines, Live Vaccines), By Application (Bacterial Infection, Viral Infection), By Species (Salmon, Trout, Tilapia), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Belgium, Netherlands, Poland, Portugal, Russia, Sweden, Switzerland, Turkey, Norway, Ireland, Denmark, Greece, Finland), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027
Published Date: February 2021 | Publisher: Graphical Research Report ID: GR1669 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Europe aquaculture vaccines industry summary, 2016 – 2027

2.1.1    Business trends

2.1.2    Type of vaccines trends

2.1.3    Route of administration trends

2.1.4    Application trends

2.1.5    Species trends

2.1.6    Country trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2016 - 2027

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1    Surging prevalence of viral and bacterial infections

3.3.1.2    Increasing aquaculture production in the region

3.3.1.3    Development and launch of new aquaculture vaccines

3.3.1.4    Rising adoption of aquaculture vaccines against antibiotics

3.3.2    Industry pitfall and challenges

3.3.2.1    Stringent regulatory policies for vaccine approval

3.3.2.2    Complex vaccine development procedures

3.4    Growth potential analysis

3.4.1    By type of vaccines

3.4.2    By route of administration

3.4.3    By application

3.4.4    By species

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive review, 2019

3.8    PEST analysis

Chapter 4   Europe Aquaculture Vaccines Market, By Type of Vaccines

4.1    Key trends in Europe aquaculture vaccines market, by technology

4.2    Inactivated vaccines

4.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.3    Live vaccines

4.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

4.4    Others

4.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 5   Europe Aquaculture Vaccines Market, By Route of Administration

5.1    Key trends in Europe aquaculture vaccines market, by route of administration

5.2    Immersion vaccines

5.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.3    Injection vaccines

5.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

5.4    Oral vaccines

5.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 6   Europe Aquaculture Vaccines Market, By Application

6.1    Key trends in Europe aquaculture vaccines market, by application

6.2    Bacterial infection

6.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

6.3    Viral infection

6.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

6.4    Others

6.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 7   Europe Aquaculture Vaccines Market, By Species

7.1    Key trends in Europe aquaculture vaccines market, by species

7.2    Salmon

7.2.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.3    Trout

7.3.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.4    Tilapia

7.4.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, by country, 2016 – 2027 (USD Million)

Chapter 8   Europe Aquaculture Vaccines Market, By Country

8.1    Key trends in Europe Aquaculture Vaccines market, by country

8.2    Germany

8.2.1.1    Market size, by country, 2016- 2027

8.2.1.2    Market size, by route of administration, 2016- 2027

8.2.1.3    Market size, by application, 2016- 2027

8.2.1.4    Market size, by species, 2016 - 2027

8.3    UK

8.3.1.1    Market size, by country, 2016- 2027

8.3.1.2    Market size, by route of administration, 2016- 2027

8.3.1.3    Market size, by application, 2016- 2027

8.3.1.4    Market size, by species, 2016 – 2027

8.4    France

8.4.1.1    Market size, by country, 2016- 2027

8.4.1.2    Market size, by route of administration, 2016- 2027

8.4.1.3    Market size, by application, 2016- 2027

8.4.1.4    Market size, by species, 2016 – 2027

8.5    Spain

8.5.1.1    Market size, by country, 2016- 2027

8.5.1.2    Market size, by route of administration, 2016- 2027

8.5.1.3    Market size, by application, 2016- 2027

8.5.1.4    Market size, by species, 2016 – 2027

8.6    Italy

8.6.1.1    Market size, by country, 2016- 2027

8.6.1.2    Market size, by route of administration, 2016- 2027

8.6.1.3    Market size, by application, 2016- 2027

8.6.1.4    Market size, by species, 2016 – 2027

8.7    Norway

8.7.1.1    Market size, by country, 2016- 2027

8.7.1.2    Market size, by route of administration, 2016- 2027

8.7.1.3    Market size, by application, 2016- 2027

8.7.1.4    Market size, by species, 2016 – 2027

8.8    Ireland

8.8.1.1    Market size, by country, 2016- 2027

8.8.1.2    Market size, by route of administration, 2016- 2027

8.8.1.3    Market size, by application, 2016- 2027

8.8.1.4    Market size, by species, 2016 – 2027

8.9    Turkey

8.9.1.1    Market size, by country, 2016- 2027

8.9.1.2    Market size, by route of administration, 2016- 2027

8.9.1.3    Market size, by application, 2016- 2027

8.9.1.4    Market size, by species, 2016 – 2027

8.10    Denmark

8.10.1.1    Market size, by country, 2016- 2027

8.10.1.2    Market size, by route of administration, 2016- 2027

8.10.1.3    Market size, by application, 2016- 2027

8.10.1.4    Market size, by species, 2016 – 2027

8.11    Greece

8.11.1.1    Market size, by country, 2016- 2027

8.11.1.2    Market size, by route of administration, 2016- 2027

8.11.1.3    Market size, by application, 2016- 2027

8.11.1.4    Market size, by species, 2016 – 2027

8.12    The Netherlands

8.12.1.1    Market size, by country, 2016- 2027

8.12.1.2    Market size, by route of administration, 2016- 2027

8.12.1.3    Market size, by application, 2016- 2027

8.12.1.4    Market size, by species, 2016 – 2027

8.13    Finland

8.13.1.1    Market size, by country, 2016- 2027

8.13.1.2    Market size, by route of administration, 2016- 2027

8.13.1.3    Market size, by application, 2016- 2027

8.13.1.4    Market size, by species, 2016 – 2027

8.14    Sweden

8.14.1.1    Market size, by country, 2016- 2027

8.14.1.2    Market size, by route of administration, 2016- 2027

8.14.1.3    Market size, by application, 2016- 2027

8.14.1.4    Market size, by species, 2016 – 2027

8.15    Poland

8.15.1.1    Market size, by country, 2016- 2027

8.15.1.2    Market size, by route of administration, 2016- 2027

8.15.1.3    Market size, by application, 2016- 2027

8.15.1.4    Market size, by species, 2016 – 2027

Chapter 9   Company Profiles

9.1    Hipra

9.1.1    Business overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.2    Zoetis Inc.

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.3    Merck & Co., Inc.

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.4    Tecnovax

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.5    Virbac

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.6    Veterquimica S.A.

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.7    Nisseiken Co. Ltd.

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    Strategic outlook
 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]